NUCLEAR MEDICINE COMMUNICATIONS, vol.36, no.2, pp.109-113, 2015 (SCI-Expanded)
Aim We aimed to assess the recurrence rates of papillary thyroid microcarcinoma in patients with and without histopathological risk factors after radioiodine (RAI) ablation treatment.